FI900670A0 - Immunoglobulin mot hiv. - Google Patents

Immunoglobulin mot hiv.

Info

Publication number
FI900670A0
FI900670A0 FI900670A FI900670A FI900670A0 FI 900670 A0 FI900670 A0 FI 900670A0 FI 900670 A FI900670 A FI 900670A FI 900670 A FI900670 A FI 900670A FI 900670 A0 FI900670 A0 FI 900670A0
Authority
FI
Finland
Prior art keywords
mot
immunoglobulin
hiv
mot hiv
immunoglobulin mot
Prior art date
Application number
FI900670A
Other languages
English (en)
Finnish (fi)
Inventor
Laurence M Cummins
Jean Pierre Allain
Jr Lawrence A Falk
Richard M Condie
Jr Henry H Balfour
Frank S Rhame
Original Assignee
Univ Minnesota
Abbott Lab N A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Abbott Lab N A filed Critical Univ Minnesota
Publication of FI900670A0 publication Critical patent/FI900670A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI900670A 1987-08-11 1990-02-09 Immunoglobulin mot hiv. FI900670A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8442687A 1987-08-11 1987-08-11
PCT/US1988/002768 WO1989001339A1 (en) 1987-08-11 1988-08-10 Hyper-immune globulin against hiv

Publications (1)

Publication Number Publication Date
FI900670A0 true FI900670A0 (fi) 1990-02-09

Family

ID=22184901

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900670A FI900670A0 (fi) 1987-08-11 1990-02-09 Immunoglobulin mot hiv.

Country Status (11)

Country Link
EP (1) EP0379516B1 (no)
JP (1) JPH0796560B2 (no)
KR (1) KR970003056B1 (no)
AU (1) AU618555B2 (no)
DE (2) DE379516T1 (no)
DK (1) DK35290A (no)
FI (1) FI900670A0 (no)
IE (1) IE62584B1 (no)
NO (1) NO180271C (no)
NZ (1) NZ225796A (no)
WO (1) WO1989001339A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640511B1 (fr) * 1988-12-15 1993-04-23 Merieux Inst Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation
EP0826005B1 (de) 1996-03-12 2004-05-12 Ovogenix Immunpharma GmbH Verwendung von aviären, vitellinen, gegen hiv-antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
WO1998001476A1 (en) * 1996-07-10 1998-01-15 Nabi Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE54757T1 (de) * 1985-02-05 1990-08-15 Us Commerce Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
EP0287226A1 (en) * 1987-03-23 1988-10-19 Hiver Limited Novel vaccines

Also Published As

Publication number Publication date
EP0379516A1 (en) 1990-08-01
NO180271B (no) 1996-12-09
IE882455L (en) 1989-02-11
KR890701133A (ko) 1989-12-19
NO900674D0 (no) 1990-02-12
NO900674L (no) 1990-02-12
IE62584B1 (en) 1995-02-08
EP0379516B1 (en) 1993-10-06
KR970003056B1 (ko) 1997-03-14
DE3884811D1 (de) 1993-11-11
NO180271C (no) 1997-03-19
DE379516T1 (de) 1991-01-17
AU2322588A (en) 1989-03-09
NZ225796A (en) 1991-08-27
JPH02504514A (ja) 1990-12-20
JPH0796560B2 (ja) 1995-10-18
AU618555B2 (en) 1992-01-02
DE3884811T2 (de) 1994-02-24
DK35290D0 (da) 1990-02-09
DK35290A (da) 1990-02-09
WO1989001339A1 (en) 1989-02-23

Similar Documents

Publication Publication Date Title
FI881129A (fi) Skyddsmaterial och -foerfarande mot elektrisk oeverbelastning.
FI864690A (fi) Skyddshoelje mot yttre vaerme- och eldpaoverkan foer straengformiga varor.
FI881042A (fi) Mot hepatocyter inriktat laekemedelstillfoerselsystem.
FI864487A0 (fi) Anordning foer laekemedelsvaord foer att mot hud rikta gnistor fraon bipolaera elektroder.
FI880824A0 (fi) Korrugerat formblock.
FI903852A0 (fi) Foerfarande foer framstaellning av ett rekombinat subenhetsvaccin mot pseudorabiesinfektion.
FI893475A (fi) Monoklonal antikropp mot en rgd-riktad adhesionreceptor av endotelceller.
FI895287A0 (fi) Monoklonal antikropp mot fukosylkeramid.
FI873266A (fi) Foerfarande foer framstaellning av ett skyddselement mot elektromagnetiska stoerningar.
FI885956A (fi) Monoklonaliska antikroppar mot lungkarcinom.
NO881105L (no) Immunoglobulin-konjugater.
NO880546D0 (no) Al-li-stoepelegeringer.
FI900498A0 (fi) Foerfarande foer producering av en antikropp mot en sjukdomspatogen.
FI900670A0 (fi) Immunoglobulin mot hiv.
FI881762A0 (fi) Foerfarande foer registrering av utvaendigt tryck mot vaevnad.
FI872802A0 (fi) Vaccin mot protozonparasiter.
FI904028A0 (fi) Bittvaol med foerbaettrad resistens mot sprickbildning.
FI900357A0 (fi) Foerfarande foer skyddande av betong mot tillfrysnings- och upptoeandeverkningar.
FI891497A0 (fi) Anordning foer hopmontering av tvao foerframstaellda elkanalelement staellda med aendarna mot varandra.
FI840687A (fi) Kondenserade benso-heterocykliska foereningar mot magsaor.
FI871738A0 (fi) Anordning foer skydd mot straolning fraon tv- eller databildskaerm.
FI875434A0 (fi) Mot skaerskador skyddande handske foer koettstyckare.
FI911586A0 (fi) Monoklonala antikroppar mot reseptor-inducerade bindningstaellen.
FI841511A0 (fi) Skydd foer traed- och buskbestaond mot immisionsskador.
FI893181A0 (fi) Skyddsanordning mot telefonterror.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: REGENTS OF THE UNIVERSITY OF MINNESOTA

Owner name: ABBOTT LABORATORIES